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ABSTRACT  A  series  of  monoclonal  antibodies  was  prepared  against  the  pepsin-resistant 
fragment  of type  IX  collagen  designated  HMW.  One  of  these  antibodies  (called  2C2)  was 
selected  for  further  analysis.  Antibody  2C2  showed  no  cross-reactivity  with  other  collagen 
types  by  inhibition  enzyme-linked  immunosorbent  assays. It recognized  an  epitope  present 
in  native  HMW,  but failed  to  recognize  any of the  three chains  of  HMW  fractionated  after 
denaturation  followed  by  reduction  and  alkylation  of  interchain  disulfide  bridges.  Electron 
microscopic  observations after rotary shadowing showed that the  location  of the epitope for 
antibody  2C2  was close  to  the  carboxy-terminus  of  HMW.  Immunofluorescent  staining  of 
sections  of embryonic and  adult cartilage with antibody  2C2  after removal  of proteoglycans 
by testicular  hyaluronidase  digestion  showed that type  IX collagen  is distributed  throughout 
the  cartilage  matrix,  and  is  not  present  in  other  connective  tissues  or  skeletal  muscle.  The 
intact  type  IX  collagen  molecule,  which  was  secreted  by  a  suspension  culture  of  freshly 
isolated embryonic chick chondrocytes, was recognized  by rotary shadowing in the presence 
of  antibody  2C2  after  first  precipitating  the  procollagens  from  the  culture  medium  with 
ammonium sulfate (30%). Two different collagenous molecules were present in the precipitate: 
a  longer  molecule  of  type  II  procollagen  (average  length,  335  nm)  with  both  amino-  and 
carboxy-propeptides  still  remaining  uncleaved,  and  a shorter molecule  (average  length,  190 
nm) which was identified  as type IX collagen. Antibody 2C2 consistently bound to the shorter 
molecules at a site  located  136 nm from  a distinctive  knob at one end of the  molecule,  and 
did  not  bind  to any specific  site  on the type  II  procollagen  molecules.  The structure  of the 
intact  type  IX collagen  molecule  with the  location  of both  collagenous  and  noncollagenous 
domains was as predicted after converting the nucleotide sequence of a cDNA clone encoding 
for one of the chains of type IX collagen to an amino acid sequence  (Ninomiya, Y., and  B.  R. 
Olsen,  1984,  Proc. Natl. Acad. Sci. USA., 81:3014-3018). 
Type IX collagen was initially isolated  from chicken sternum 
as  two  pepsin-resistant  fragments  designated  HMW  and 
LMW (1, 2) or MI  and M2 (3). Subsequent studies  showed 
that  the  intact  molecule  from  which  these  fragments  are 
derived is much larger (4-7), and that both fragments may be 
derived from a single molecule (6). Three genetically  distinct 
chains were fractionated from both LMW (8, 9) and HMW 
(10).  The three  chains were  consistently present  in  a  l:l:l 
proportion for both HMW and LMW, and it was proposed 
that there is a single type IX molecule of chain organization 
814 
al(IX)a2(lX)a3(lX)  (8-10).  A  cDNA  clone  (called  pYN 
1738) was prepared from chick chondrocyte RNA and shown 
to encode for one of the chains of both HMW and LMW 
(11). The DNA sequence of this  clone was converted to an 
amino  acid  sequence  and  this  sequence  compared  to  the 
amino  acid  compositions  of the  tryptic  peptides  and  the 
amino-terminal sequences  of the three chains of both HMW 
and LMW (10). By this approach, it was possible to determine 
which of the three chains of HMW and LMW are encoded 
for by the  cDNA clone pYN  1738, and  to determine  the 
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molecule. This chain was designated the al(IX) chain (10), 
and subsequently a second cDNA clone (called pYN  1731) 
was  identified which encodes for approximately one-half of 
the a2(IX) chain (12). 
Recently, genomic clones were isolated for the al(IX) and 
a2(1X) chains (13),  and it is anticipated that the complete 
amino acid sequences of the chains of type IX collagen will 
eventually  be  determined  with  DNA  sequencing  studies. 
However, the function of type IX collagen in cartilage matrix 
still  remains unknown, and to examine the location of this 
collagen in cartilage matrix, we now describe the preparation 
and characterization of a monoclonal antibody (called 2C2) 
of high  affinity for type  1X  collagen.  The  location of the 
epitope for antibody 2C2 was determined by rotary shadowing 
of the antibody in the presence of both HMW and the intact 
type IX collagen molecule as secreted by a suspension culture 
of freshly isolated chondrocytes. 
MATERIALS  AND  METHODS 
Preparation  of Collagens:  Type  1 collagen was prepared  from an 
acid extract of lathyritic chicken skin (14). Type II collagen, HMW, and LMW 
were isolated from a pepsin digest of adult chicken sterna and further fraction- 
ated by differential salt precipitation  in acid conditions as previously described 
(1).  Further purification  of type  11  collagen was achieved as the  precipitate 
obtained during differential salt precipitation  between 0.7-0.8  M NaCI, 0.5 M 
acetic acid. HMW and LMW were fractionated by molecular sieve chromatog- 
raphy (Bin-Gel A-5m) (Bio-Rad Laboratories,  Richmond,  CA) without  prior 
denaturation  of the sample (2). Further purification of HMW was achieved by 
CM-cellulose chromatography  in nondenaturing  conditions (15), and of LMW 
by an additional  passage over the molecular sieve column. Types 111, IV, and 
V collagens were obtained  by limited pepsin digestion of adult chicken gizzard 
and separated by differential salt precipitation  in acid and neutral conditions 
(15, 16). Type X collagen (59 kD form) was isolated from the medium of long- 
term cultures of chondrocytes from chick tibiotarsus (17), and was a gift from 
Dr. Thomas M. Schmid,  Department  of Biochemistry, Rush-Presbyterian-St. 
Luke's  Medical Center,  Chicago. For some experiments,  HMW was reduced 
with 2-mercaptoethanol  (fl.l M,  100*C, 2 min) and alkylated with iodoacetic 
acid (0.2 M) at room temperature  before being separated into three fractions 
(called C-2 + C-5, 03, and C-4) by molecular sieve chromatography  (Bin-Gel 
A-l.5m), as described  previously (2). In earlier work C-2 was regarded as a 
single chain of HMW (2), but further experiments have shown that C-2 can be 
fractionated  by  reverse-phase high performance  liquid  chromatography  into 
two chains now designated C-2 and C-5 (10). However, the separation of 02 
and C-5 was not carried out in the present series of experiments. The fragments 
C-3 and C-4 represent the third chain of HMW, and arise from the cleavage of 
this chain in a noncollagenous domain called NC3 between two triple helical 
domains called COL2 and COL3 (2,  10,  11). 
Hybridoma  Production:  Female  BALB/c mice (6-8 wk old) were 
initially  immunized  with  100 ug of HMW emulsified  in complete  Freund's 
adjuvant;  the  injections  were  made  subcutaneously  into  the  rear  footpads, 
inguinal and axial regions. A similar injection in incomplete Freund's adjuvant 
was given 3 d later, and then at 3-4-d intervals four more injections were given 
with the antigen dissolved in physiological saline.  1 d after the last injection, 
the  local lymph  nodes  draining  the  subcutaneous  areas  of injection  were 
removed and a cell suspension was prepared before fusion. 
The preparation  of hybridomas  was described in detail elsewhere (18) and 
was performed  by  the  staff of the  Hybridoma Core  Facility,  Multipurpose 
Arthritis Center,  University of Alabama  at Birmingham.  Briefly, lymph node 
cells and myeloma cells (P3x63A8.653)  were both washed in serum-free RPMI- 
1640 medium and then combined  in a 2:1  ratio and pelleted. The cells were 
agitated with I ml PEG-4000 at 37"C for 30 s before being slowly diluted with 
serum-free  RPMI-1640  medium at  37"C. Ceils were briefly centrifuged and 
resuspended in hypoxanthine/amiuopterin/thymidine medium. Peritoneal ex- 
udate feeder cells were added  and the suspension  plated (1  ml/well) into 24- 
well Costar  plates  to give  5  ×  l0  s  lymph  node  cells/well.  After  2-3  wk, 
hypoxathine/aminopterin/thymidine medium  was  replaced  by  normal  me- 
dium.  Hybridomas which grew and produced  antibodies  against HMW were 
cloned several times by limiting dilution. Ascites fluid was prepared by injecting 
10  7 hybridoma  cells into  BALB/c female mice primed  with Pristane (0.5 ml, 
Aldrich Chemical Co.,  Milwaukee, WI). After 2-3 wk, ascites fluid was har- 
vested, briefly centrifuged, and protease inhibitors added to the supernatant. 
Purification and Characterization of Monoclonal Antibod- 
ies:  lmmunoglobulins  were precipitated from ascites fluid with ammonium 
sulfate (50% of saturation,  4"C), and  the  precipitate  redissolved in 0.01 M 
phosphate-buffered saline (PBS), pH 7.2. After extensive dialysis against PBS, 
further purification  of each antibody was achieved by passage over an HMW 
affinity column prepared by coupling HMW to Sepharose-4B (Pharmacia Fine 
Chemicals, Piscataway, N  J) using published procedures (19, 20). Each antibody 
was eluted wtih 3 M KSCN, 0.05 M PBS, pH 6.0, dialyzed immediately against 
PBS, and concentrated  by ultrafiltration  before being stored in the presence of 
protease inhibitors. Enzyme-linked immunosorbent assays (ELISAs)  ~  for each 
antibody  were performed  with a  Hybridoma  Screening  Kit  specific for the 
mouse lgG class (Bethesda Research Laboratories, Gaithersburg,  MD) as de- 
scribed previously (21). Each antibody  preparation  was also analyzed by SDS 
PAGE  (5-10%  gradient  slab  gel), and  the  subclass  of each  antibody  was 
determined by ELISAs. The anti-isotype reagents were purchased from South- 
ern Biotechnology Associates, Birmingham, AL. 
Electron Microscopic Observations of Collagen/Antibody 
Binding:  The procedures have been described in detail elsewhere (20, 22). 
A mixture of the collagen and antibody (25 u.g/ml each) were dialyzed against 
0.2 M ammonium bicarbonate (pH 7.9) before spraying. Lengths of molecules 
and  the  location  of antibody  binding  sites were  measured  using a  Science 
Accessories GrafPen 3 Sonic digitizer interfaced with a Hewlett-Packard 9825A 
(Hewlett-Packard Co., Pain Alto, CA) programmable calculator. Calibration of 
the electron microscope was achieved using a grating replica of  silicon monoxide 
(21,600 lines/cm,  Ernest F. Fullam, Inc., Schenectady, NY). 
Immunofluorescence  Observations:  The procedures  used were 
described in detail previously (23). Frozen sections (5 izm) were prepared from 
the sterna  of 18-d chick embryos and from the  sterna  of adult  chicken and 
quail. All sections included the connective tissue of the outer perichondrium 
and some skeletal muscle. Sections were dried onto slides (30 min,  4"C) and 
some were treated  with bovine testicular  hyaluronidase  (1%, Type  I, Sigma 
Chemical Co., St. Louis, MO) dissolved in 0.01 M PBS, pH 7.2, for 30 min at 
room temperature  (24). After washing {0.01 M PBS, pH 7.2), sections were 
treated  with  primary  antibody  (30  rain,  room  temperature).  The  primary 
antibodies were present in the undiluted culture supernatants  from hybridoma 
2C2  against  HMW and,  as  a  control,  from  hybridoma  IIrB3(15A,) against 
chicken type I1 collagen (25). After washing in PBS, sections were exposed to a 
fluorescein-conjugated lgG fraction of goat anti-mouse  IgG (Cappel Laborato- 
ries, Cochranville, PA) diluted 1:40 in PBS. After 30 min, sections were washed 
extensively in PBS, mounted with a coverslip and a drop of 90% glycerol, and 
observed  in  a  Leitz Ortholux  11  microscope  equipped  for  epifluorescence. 
Photographs were taken with Kodak Tri-X  film rated at ASA  1,600. Control 
sections either did not receive a primary antibody,  or antibody  IA8 was used 
which  recognizes an  epitope  in  the  (FI)2F2  domain of type  IV  (basement 
membrane) collagen (21 ). Controls consistently gave no fluorescent staining of 
hyaline cartilage. 
Rotary Shadowing of Collagens Secreted by Suspension 
Cultures of Chick Chondrocytes:  Approximately80-lOOsternawere 
dissected from 17-d chick embryos and incubated for 2 h at 37°C in basal salts 
solution (50 ml) containing collagenase (CLS, 1 mg/ml, Worthington Biochem- 
ical Corp., Freehold, N  J) and trypsin (2.5%, 5 ml, Gibco Laboratories, Grand 
Island, NY) in an atmosphere  of 95% 02:5% CO2. Cells were liberated from 
the  matrix  by repeated  pipetting and  isolated by filtration  through  a double 
layer of lens paper.  The  cells were washed with  Eagle's minimum essential 
medium  (four times) containing  10% fetal calf serum,  I% antibiotic/antimy- 
cotic  mixture  and  1%  L-giutamine (all from Gibco  Laboratories).  The  cells 
were  washed  once  in  the  same  solution  with  the  serum  reduced  to  1%, 
resuspended in the low serum solution (20 ml), counted, and incubated at 37"C 
for 2 h in an atmosphere  of 95% 0::5% COs. Cells were centrifuged from the 
medium, the medium cooled to 4"C, and protease inhibitors added. The final 
concentration  of protease inhibitors  was 0.2 mM phenylmethylsulfonyl  fluo- 
ride,  10 mM N-ethylmaleimide, 2.5 mM EDTA and 0.25 mM ~-aminocaproic 
acid.  A saturated  solution  of ammonium sulfate was added  to give a  final 
concentration  of 30%  saturation  and  the  mixture  allowed to stand  at  4*C 
overnight.  The precipitate  obtained  after  centrifugation  (48,000 g,  I  h) was 
dissolved in 0.2 M ammonium bicarbonate (2 ml) and dialyzed against several 
changes of this solution before spraying for rotary shadowing. In some experi- 
ments, a solution  of monoclonal  antibody  2C2  was added  before dialysis to 
give a ~,nal concentration  of 12.5 ~g/ml. 
3  Abbreviation  used in this paper.  ELISA, enzyme-linked immuno- 
sorbent assay. 
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Antibody Isolation and Characterization 
Initially, two hybridomas (designated 2C2  and 4D6)  were 
selected which  secreted monoclonal antibodies of high titer 
against  HMW  in  ELISAs. Ascites fluid was prepared from 
each hybridoma and the secreted antibodies were purified by 
ammonium sulfate precipitation (50% of saturation), followed 
by elution from an HMW affinity column. Further character- 
ization of the antibodies showed that 2C2 and 4D6 were both 
of the subclass IgG 1. 
Fig.  1 shows an inhibition ELISA performed with 2C2 and 
a variety of collagen types. Inhibition was only observed with 
HMW and not with collagen types I, II, III, IV, and V or with 
LMW. In separate ELISAs type X collagen also did not inhibit 
the binding of 2C2 to HMW (data not shown). For antibody 
4D6, inhibition ELISAs could only be performed successfully 
at high  concentrations of HMW.  These results suggest  that 
4D6 has a relatively weak affinity for HMW, and subsequent 
experiments were performed largely with 2C2. 
Location of the Epitope for 2C2  in HMW 
Fig. 2A shows an inhibition ELISA performed with HMW 
which had first been heated to 55°C for 30 min in inhibition 
buffer. This temperature was previously shown to denature 
the collagen triple helix of HMW (5). However, the ability of 
HMW to inhibit remained unaffected. One possible explana- 
tion for this result is that the epitope for 2C2 is not dependent 
on the native conformation of HMW. The individual chains 
of HMW were then isolated and tested by inhibition ELISAs, 
but little or no inhibition was observed (Fig. 2B). A second, 
more likely,  possibility is that during cooling of HMW after 
denaturation, the triple helix of HMW renatured and at the 
same time the epitope was restored. Previously, it was shown 
by both rotary shadowing (2) and by optical rotation (5) that 
only the long arm of HMW renatures after cooling HMW. 
These results therefore suggest  that the epitope for 2C2  may 
0'4. 
I 
0.4' 
~  03 
ul 
}o 
01- 
0.5' 
LMW  o 
HMW 
o.ol  o:i  i:o  ;0  I~o 
CONCENTRATION  OF  INHIBITOR  (l~g/ml) 
FIGURE  1  An  inhibition  ELISA using  antibody  2C2  and  various 
(oncentrations of native collagens (abcissa) as inhibitors. The upper 
solid line shows the lack of inhibition by collagen types I (A), II (@), 
III (O), IV (0), and V (0). LMW  (El), which is a separate component 
of the  type  IX  molecule (10),  also  showed  no  inhibition.  Strong 
inhibition was, however, observed with HMW (11). 
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FIGURE  2  (A)  Inhibition  ELISA performed  with  HMW  in  which 
one-half of the  sample was  heated to  55°C  for  30  rain  prior to 
incubation with 2C2. HMW  unheated (11), HMW  heated (R).  Note 
that prior denaturation of HMW  did not affect its ability to inhibit 
during ELISA. (B) Inhibition ELISA performed with peptides of HMW 
isolated  after  reduction  and  alkylation  of  interchain  disulfide 
bridges, and  subsequently  fractionated  by  molecular sieve chro- 
matography. The  peptides used  were a  mixture of C-2  and  C-5 
chains (~), C-3 (A), and C-4 (O). Little or no inhibition was observed 
with any of the peptides. 
be located in the long arm of HMW. 
Direct evidence for the location of the epitope for 2C2 was 
obtained by rotary shadowing of mixtures of HMW and 2C2 
purified from ascites fluid (Fig.  3A ). Antibody 2C2 was con- 
sistently observed binding close to or at the end of the long 
arm of HMW (arrows). To demonstrate that this binding did 
not arise from a nonspecific interaction of antibody 2C2 with 
HMW, rotary shadowing was also performed with antibody 
AB12 previously prepared against type V collagen (23).  An- 
tibody AB12 was chosen as a  control since it is also of the 
IgG1 subclass (23).  No specific binding of ABI2 to any site 
along  the  HMW  molecule  could  be  observed  (data  not 
shown). Rotary shadowing was also performed with antibody 
4D6 which was isolated from ascites fluid and subsequently 
eluted  from an  HMW affinity column.  For antibody 4D6, 
specific binding occurred to the end of  the short arm of HMW( 
Fig.  3 B, arrows). A second, shorter population of molecules FIGURE  3  Electron  micrographs after rotary shadowing of antibodies 2C2 (A) and 4D6 (B) interacting with the fragment of type 
IX collagen called HMW. The antibody (25 ~,g/ml) and the antigen (25 ~,g/ml) were mixed together and dialyzed overnight against 
0.2  M  ammonium bicarbonate (pH  7,9) before addition of glycerol (40%). The mixture was sprayed onto freshly  cleaved mica 
and shadowed with platinum at 9 ° followed by carbon at 90 °. Note that in A (single arrowheads) antibody 2C2 binds to the end 
of the long arm of HMW  whereas in  B (single arrowheads) antibody 4D6  binds to the end of the short arm of HMW.  Circles 
indicate three molecules in B for which the short arm of HMW  has apparently bent back onto the long arm, Double arrows 
indicate antibodies which appear to be cross-linking two HMW molecules. Bar, 100 nm. x  89,000. was also observed which exhibited antibody binding close to 
the center of the molecule (Fig.  3B,  circles).  The probable 
explanation for the structure of these latter molecules is that 
the short arm of HMW has folded back onto the long arm of 
HMW. Occasionally,  antibody molecules were also observed 
which appeared to cross-link  two HMW molecules (double 
arrows). These results show that, although antibody 4D6 binds 
weakly  to  HMW  as  judged  by  the  inhibition  ELISA, the 
affinity of  4D6 for HMW nevertheless is such that the location 
of its epitope can be visualized by rotary shadowing. 
A  total  of three  antibodies  (2C2,  4D6,  and  AB12)  were 
therefore examined by rotary shadowing for binding to HMW. 
Of these,  only antibody 2C2 bound to the end  of the long 
arm of HMW, and this result therefore strongly suggests that 
this is the location of the epitope for 2C2, and that the result 
is not due to nonspecific binding. Quantitation of the binding 
of 2C2 to HMW was achieved by analysis  of the individual 
molecules of HMW that could be distinguished  after rotary 
shadowing.  Examples of four major populations of molecules 
that were observed are illustrated  in Fig. 4. Row A illustrates 
a  population  of molecules that  lacked  the  presence  of an 
antibody.  Sometimes  a  kink  could be  recognized in  these 
molecules between the short and long arms of HMW. In row 
B,  molecules of similar  length  are  illustrated  but  with  an 
FIGURE  4  Gallery  of  selected  molecules  of  HMW  after  rotary 
shadowing  in  the  presence  of  monoclonal  antibody  2C2  as  de- 
scribed  for  Fig.  3.  Row A  shows  molecules without attached anti- 
body; Row B shows molecules with antibody bound at one end but 
without a prominent kink; Row C shows molecules with a kink and 
with  an  antibody molecule  bound  at the  end  of the  long arm  of 
HMW;  Row  D  shows  shorter  molecules with  antibody  bound  at 
one end. Close examination of several of the molecules in row D 
suggests that  the  short  arm  of  HMW  is  bent  back  onto the  long 
arm. Bar,  100 nm. ×  119,000. 
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antibody bound to  one  end,  and  in  row  C  molecules are 
shown with a kink and an antibody bound near the end of 
the long arm of HMW. In row D, a second shorter population 
of molecules is shown with an antibody bound to one end. It 
is probable that for many, if not all, of  these shorter molecules 
the short arm of HMW has folded back onto the long arm of 
HMW. Indications of this can be observed for some of the 
molecules illustrated  in row D. This conclusion is also sup- 
ported by the shorter molecules observed in Fig. 3 B (circled 
molecules)  in which the binding of antibody 4D6 is at the 
expected  location if the short arm of HMW has folded back 
onto the long arm. 
Of a total of 176 molecules examined, two populations of 
molecules could be recognized regardless  of their ability  to 
bind antibody: long molecules of 101-146 nm (72% of total, 
mean length --- 125 nm, SD, +_. 8 nm) and shorter molecules 
of 70-100 nm (28% of total,  mean length =  87 nm, SD, +_ 8 
nm). The differences between the length of the long and short 
molecules is 38 nm and this is the same as the length previ- 
ously determined for the short ann of HMW (2). This result, 
therefore,  provides additional evidence that the short mole- 
cules of HMW arise from the folding back of the short arm 
onto the long arm. Of the total molecules examined (long and 
short),  136 (77%) possessed  an antibody located at one end 
of  the molecule, whereas only 32 (18%) possessed an antibody 
located anywhere else along the molecule.  Of the long mole- 
cules,  86 (68%)  possessed  a recognizable  kink and, of these 
86 molecules,  69 (80%) possessed an antibody located at the 
end of the long arm. Only 17 (20%)  possessed  an antibody 
located elsewhere along the molecule.  These results  demon- 
strate  that a very high proportion of HMW molecules bind 
2C2  at  only one  site  and,  by examining molecules which 
display a kink, the binding site can be localized close to or at 
the end of the long arm of HMW. 
The lengths  of several different  populations of long mole- 
cules  as illustrated  in Fig. 4 were  also  measured.  For those 
molecules which did not possess an antibody binding at one 
end (20 molecules,  Fig. 4A), the average length  was  136 nm 
(SD, +_ 8 nm), this value  agreeing closely with our previous 
value of 134 nm for the length of HMW (2). This measure- 
ment was made regardless of whether or not a kink could be 
recognized for each molecule.  Measurements of long mole- 
cules without a kink but with an antibody located at one end 
(25  molecules,  Fig. 4B) gave  a  value of 123  nm (SD,  ___  6 
nm), this being shorter than the measurement of molecules 
without an antibody at the end ( 136 nm). It therefore appears 
that the antibody may shield  a part of HMW during rotary 
shadowing as measurements were made only up to where the 
binding of the antibody to HMW could first be recognized. 
Measurements of molecules with a kink and with an antibody 
at the end of  the long arm (86 molecules,  Fig. 4 C) gave values 
of 86 nm (SD,  _  10 nm) and 39 nm (SD,  +_ 7 nm) for the 
long and short arms, respectively. The value of 39 nm agrees 
well with  the value of 38 nm previously determined for the 
length of the short arm of HMW (2). However, the value of 
86 nm is less than the value of 96 nm previously determined 
for the length of the long arm (2) and again suggests that the 
antibody may be shielding  a small part of the long arm. The 
sum of the long and short arms (125  nm) agreed  well with 
the  length  of 123  nm determined  for molecules without a 
kink but with an antibody binding to one end.  These  mea- 
surements therefore all suggest that the epitope for 2C2 may 
be located at a short distance (10-15 nm) from the noncolla- genous carboxy-terminus of HMW. 
Fig.  5  shows  immunofluorescent staining  of  18-d  chick 
embryo  sternum  with  monoclonal  antibody  II6B3(15A4) 
against type II collagen (A and B) and monoclonal antibody 
2C2 against type IX collagen (C and D). A shows that without 
hyaluronidase  treatment,  immunofluorescent  staining  for 
type II collagen was  present only at the outer edges of the 
cartilage matrix close to the perichondrium. However, after 
hyaluronidase  treatment  (B),  fluorescent  staining  was  ob- 
served throughout the cartilage matrix. These results were the 
same as previously reported for immunofluorescent staining 
of chick cartilage with a polyclonal antibody against type II 
collagen (24). For antibody 2C2, without hyaluronidase treat- 
ment, some immunofluorescent staining for type IX collagen 
was observed throughout the cartilage matrix (C). However, 
after hyaluronidase treatment, fluorescent staining was much 
brighter and of equal intensity throughout the matrix (D). In 
all sections, fluorescent staining was not present in the outer 
connective tissue of the perichondrium, nor in  the skeletal 
muscle associated with the sternal cartilage. 
Monoclonal antibodies against type II and type IX collagens 
were both  found to  cross-react with  quail  cartilage.  Fig.  6 
shows  immunofluorescent staining  of adult  quail  sternum 
with antibody II6B3(15A4) against type II collagen (,4 and B) 
and antibody 2C2 against type IX collagen (Cand D). Sections 
shown in B and D were treated with hyaluronidase prior to 
immunofluorescent staining. For type II collagen,  immuno- 
fluorescent staining was observed only in the outer cartilage 
unless the sections were first treated with hyaluronidase (com- 
parison of  A and B). For type IX collagen, without hyaluron- 
idase  treatment,  fluorescent staining  occurred both  in  the 
outer cartilage and also in a pericellular location around the 
inner chondrocytes (C). However, after hyaluronidase diges- 
tion,  fluorescent  staining  occurred  with  equal  intensity 
throughout  the  cartilage  matrix  and  was  the  same  as  the 
staining pattern for type II collagen. No staining for type II 
or type IX collagen was  observed for the outer connective 
tissue or for the skeletal muscle attached to the sternum. Very 
similar results with both antibodies were also obtained for 
adult chicken sternum. However, antibody 2C2 did not show 
fluorescent staining of adult rat or guinea pig xiphoid process 
or the matrix of a  transplantable rat chondrosarcoma (data 
not presented). With antibody 4D6, immunofluorescent  stain- 
ing patterns identical to those for 2C2 were observed with and 
without hyaluronidase digestion for chick embryo sternum 
and adult quail sternum. 
The results for both embryonic and adult  sterna suggest 
that without hyaluronidase digestion type IX collagen is more 
readily accessible to antibody than type II collagen, especially 
in  the  central  region  of the  embryonic sternum  and  in  a 
FIGURE 5  Indirect immunofluorescent  staining of sections of chick sternal cartilage from 18-d embryos with monoclonal  antibody 
116B3(15A4)  against type II collagen (A and B) and monoclonal antibody 2C2 against type IX collagen (C and D). Sections in B and 
D were treated with hyaluronidase (1%) prior to immunofluorescent staining. Note that fluorescent staining for both type II and 
type IX collagen was present  throughout the sternum  only if the glycosaminoglycans  were first  removed with  hyaluronidase. 
x  234. 
IRWIN et AL.  Monoclonal  Antibody Against Type IX Collagen  819 FIGURE 6  Indirect immunofluorescent staining of sections of adult quail sternal cartilage with antibody II6B3(15A4) against type II 
collagen (A and B) and antibody 2C2 against type IX collagen (C and D). Sections in B and D were treated with hyaluronidase 
(1%) prior to immunofluorescent staining. Note that without hyaluronidase treatment immunofluorescent staining for both type 
II and type IX collagen was predominantly at the outer surface of the sternum (A and C). For type IX collagen (C), some pericellular 
fluorescent staining was also observed. After hyaluronidase treatment,  fluorescent  staining for both type II and type IX collagen 
was present throughout the cartilage matrix. (A-C) x  375; (D), x  234. 
periceilular  location  around  the  chondrocytes of the  adult 
sternum. However, after hyaluronidase digestion, the fluores- 
cent staining patterns for type II and type IX collagens were 
the same and indicate an equal distribution of the two colla- 
gens throughout the cartilage matrix. 
Experiments were  performed to  examine  the  binding  of 
2C2  to the  intact type IX collagen  molecule secreted by a 
suspension culture of freshly isolated chondrocytes. Two pop- 
ulations  of molecules  were  recognized  in  the  ammonium 
sulfate precipitate of the medium and  selected examples of 
these molecules are illustrated in Fig. 7. The longer molecules 
(rows A and B) possessed a prominent knob at one end and 
a sharp kink at the opposite end (arrows) and were identified 
as type II procollagen, although a few of these molecules may 
also be a procollagen form of l a,2a,3a collagen (1). A similar 
sized knob was previously observed at the carboxy-terminus 
of type I  procollagen after rotary shadowing (26),  and  it is 
known that the carboxy-terminal propeptide of type II pro- 
collagen is similar in size and structure to the propeptides of 
type I procollagen (27,  28).  The overall length of the type II 
procollagen molecules including the knob was 335  nm (SD, 
___ 12 nm, 91 molecules measured); this compares closely with 
the  published  value of 330  nm  for type I  procollagen (26). 
The kink is probably located at a  short noncollagenous do- 
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main containing the amino-terminal (NH2-terminal) propep- 
tidase cleavage site. A kink at a similar location was previously 
observed for type I pN-collagen (29,  30). However, the NH2- 
terminal propeptide of chick and rat type II procollagen differ 
from the NHE-terminal propeptide of type I collagen in lack- 
ing a large globular domain and containing a longer collage- 
nous domain (31,  32). This explains why we were unable to 
observe a globular domain at the amino terminus of type II 
procollagen after rotary shadowing as  can  be  observed for 
type I pN-collagen (29,  30). The presence of a longer collag- 
enous domain for type II procollagen also explains why the 
length  we  observe  from  the  kink  to  the  amino-terminus 
appears  longer  than  for  the  type  I  pN-collagen  molecules 
previously examined by rotary shadowing (29). 
For type II procollagen molecules, the possible binding of 
antibody 2C2 was analyzed after rotary shadowing; of 42 type 
II procollagen molecules examined only 12 showed an anti- 
body apparently binding anywhere along the molecule. The 
length from each antibody to the knob of the carboxy-termi- 
nus was measured, and the results showed that there was no 
consistent  binding  of antibody  2C2  to  any  site  along the 
procollagen II molecule (data not presented). 
A second population of shorter molecules was also promi- 
nent among the collagens secreted by short-term cultures of FIGURE  7  Electron  micrographs of representative collagen mole- 
cules  secreted  by  embryonic chick  chondrocytes and  observed 
after  rotary shadowing in  the  presence of  monoclonal antibody 
2C2.  Freshly isolated embryonic chondrocytes were incubated for 
2  h and the collagens  precipitated from the medium with ammo- 
nium sulfate.  The  precipitate was dissolved in  0.2  M  ammonium 
bicarbonate and  rotary shadowing performed in  the presence of 
antibody 2C2  (12.5  #g/ml) after extensive dialysis  against  0.2  M 
ammonium bicarbonate. Rows A and B show type II  procollagen 
molecules with a kink (arrows) at the amino-terminus and a knob 
at the carboxy-terminus. Rows C-E show type IX molecules with a 
smaller knob at the amino-terminus  and a characteristic kink located 
47 nm from the knob. Note that monoclonal antibody 2C2 consis- 
tently bound to a site which was located 136  nm from the knob. 
Occasionally, antibody molecules were randomly located at other 
sites along the molecule. The angle of the kink was not fixed, and 
was not observed in all molecules. Bar, 100 nm. x  124,000. 
chick chondrocytes.  A  series of representative molecules is 
shown in Fig.  7, rows C-E. Each molecule possessed a small 
knob  at  one  end,  and  the  total  length  of the  molecules 
including the knob was 190 nm (SD, +  8 nm,  112 molecules 
measured).  In addition,  a  prominent kink was consistently 
present in 95% of the molecules at a distance of 47 nm (SD, 
___  5  nm,  106  molecules  examined)  from  the  knob.  In  a 
preparation which contained antibody 2C2, of 92 molecules 
examined, 81 (88%) showed an antibody molecule binding at 
a site located  136 nm (SD, _+ 6 nm) from the knob. Only 20 
of the  molecules  (22%)  showed  a  2C2  antibody  molecule 
located  elsewhere in  a  random  manner along the  type IX 
molecule. For the intact type IX molecule, the length from 
the kink to the antibody was 89 nm, this comparing closely 
to the previous value of 86 nm for the binding of antibody to 
HMW. The length from the antibody to the carboxy-terminus 
of the intact type IX molecule was 54 nm of which it can be 
calculated that only 30-35 nm is represented by LMW. These 
results therefore also suggest that antibody 2C2 may not bind 
to the carboxy-terminus of HMW but binds at a short distance 
(10-15 nm) from the terminus. 
Rotary shadowing of the intact type IX molecule was also 
performed in the presence of antibody 4D6 but only a  few 
antibody molecules were observed at the expected site close 
to the knob (unpublished observations). It therefore appears 
that 4D6 may be recognizing an epitope present within the 
pepsin-generated amino terminus of HMW, but this epitope 
may not be readily available in the intact type IX molecule. 
These results demonstrate that the structure of the type IX 
molecule as predicted  from the  nucleotide  sequence  of the 
cDNA clones pYN1738 (9-11) and pYN1731 (12) is entirely 
consistent  with  the  structure  of the  type  IX  molecule  as 
secreted by chick chondrocytes. The knob must represent the 
noncollagenous amino-terminal domain called NC4 and the 
kink is located at the NC3 domain between the collagenous 
domains COL3  and  COL2,  or between  the  short and  long 
arms of HMW. The extension of the intact type IX molecule 
beyond the binding site for antibody 2C2 as observed in Fig. 
7  must  be  largely  represented  by  the  collagenous  domain 
COL1 or LMW. From the nucleotide sequences of the cDNA 
clones pYNI738  and  pYN1731  (11,  12) it can be deduced 
that  there  is  only  a  small  noncollagenous  domain  at  the 
carboxy-terminus of the  intact  type  IX  molecule and  this 
would not be large enough to be visualized after rotary shad- 
owing. The angle of the  kink between COL3 and COL2 at 
NC3 was variable and molecules were often observed in which 
COL3 was bent back completely onto COL2 (Fig.  7, row E, 
third molecule from left). At no time were type IX molecules 
observed which  interacted with each other to form a  struc- 
tured aggregate. 
DISCUSSION 
Although the overall structure of type IX collagen is now well 
understood (l-12),  the function of this collagen in cartilage 
matrix is  still  unclear.  To  achieve high  resolution  electron 
microscopic immunolocalization of type IX collagen in car- 
tilage matrix, we have begun to prepare a series of monoclonal 
antibodies directed against different epitopes of the type IX 
molecule. Of the two antibodies initially selected,  only 2C2 
bound to HMW with high affinity, and only with this antibody 
could the  location of its epitope be recognized after rotary 
shadowing of both HMW and the intact type IX molecule. 
Antibody 2C2  is therefore the only one which fulfills  all of 
our desired properties, and it will be used predominantly for 
future experiments. 
Our present rotary shadowing observations (Fig. 3A) show 
that the epitope for 2C2 is located at or close to the carboxy- 
terminus of HMW and could therefore be located within the 
noncollagenous NC2 domain of the intact type IX collagen 
molecule. At present, we do not know how much of the NC2 
domain  remains  after pepsin  digestion  to  produce  HMW. 
Sequencing of cDNA clones pYN1738 and pYN 1731 shows 
that the total number of amino acids in NC2 is thirty for both 
the al(IX) and a2(IX) chains (10,  12). However, amino acid 
sequencing shows that some of these amino acids are located 
at the amino termini of the three chains of LMW (9). Within 
the NC2 domain the ~l(IX) chain contains a single cysteine 
(10),  whereas the a2(IX) chain is without cysteine (12).  It is 
not  known  if this  cysteine  forms a  disulfide  bridge  to  the 
a3(IX) chain or if it is present in HMW. The other possibility 
is that the epitope for 2C2 is located within the triple helix of 
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HMW. The antibody may then shield the carboxy-terminus 
of HMW during rotary shadowing. This would explain why, 
after denaturation of HMW, the epitope returned completely 
as judged by the inhibition  ELISA (Fig.  2A).  Previously, it 
was  shown  by  both  rotary  shadowing  (2)  and  by  optical 
rotation  (5)  that the triple helix  of the  long arm of HMW 
rapidly  renatured  after  HMW  was  denatured  and  subse- 
quently brought to room temperature. 
Several studies using polyclonal antibodies to fragments of 
type IX collagen have  reported immunolocalization to the 
pericellular  matrix  of chondrocytes  in  adult  pig  articular 
cartilage (33), the epiphyseal cartilage of developing fetal calf 
long bones (34), and bovine nasal cartilage (35). Furthermore, 
electron  microscopic immunolocalization with a  secondary 
antibody coupled to peroxidase suggested that type IX colla- 
gen  is  present  in  fine  nonstriated  fibrils of the  pericellular 
matrix (36).  Similar fibrils have been observed in the pericel- 
lular capsule of adult canine articular cartilage and suggested 
to contain type IX collagen (37).  In all of the above studies, 
proteoglycans were removed from the sections by digestion 
with hyaluronidase prior to staining. In our experiments, we 
performed similar digestion with hyaluronidase using sections 
of embryonic and adult sterna, and observed immunofluores- 
cent localization of type IX collagen throughout the cartilage 
matrix (Figs.  5 and 6).  The same distribution  was also ob- 
served for type II collagen after hyaluronidase digestion but, 
without hyaluronidase treatment, no staining for type II col- 
lagen occurred in  the  center of the sternum.  However, for 
embryonic sterna without hyaluronidase digestion, some im- 
munofluorescent staining for type IX collagen was observed 
throughout  the  matrix (Fig.  5,  C),  and  in  adult  sterna the 
staining was present in a pericellular location (Fig.  6,  C).  It 
therefore appears that type IX collagen may be more readily 
available for immunofluorescent staining than type II colla- 
gen.  The pericellular staining observed previously by other 
investigators may be due to staining only of the fraction of 
the type IX collagen to which the  antibody can penetrate, 
while the remainder of the type IX collagen continues to be 
masked. 
Recently, a type IX collagen preparation was isolated from 
rat chondrosarcoma and examined by rotary shadowing (38). 
The molecule appeared to be somewhat shorter than reported 
here (171  vs.  190 nm) and sometimes showed a  prominent 
kink  towards  one  end.  The  noncollagenous  knob  of the 
amino-terminus was  not  present,  and  may have been  lost 
either by an NH2-terminal processing event or by nonspecific 
protease  activity.  For  chick  type  IX  collagen,  the  amino- 
terminus appears to be the most easily cleaved by pepsin (7), 
and  may also be sensitive to other proteases. We have not 
observed the lateral end-to-end associations of two type IX 
molecules as were  observed previously for rat chondrosar- 
coma type IX collagen (38). 
The use of monoclonal antibodies combined with  rotary 
shadowing may be applicable to analyses of the structure of 
several large collagenous molecules which cannot be readily 
isolated or fractionated.  Previously, we prepared a  series of 
monoclonal antibodies against different pepsin-resistant frag- 
ments of chicken type IV collagen, and used these antibodies 
combined with rotary shadowing to immunomap the pepsin- 
resistant fragments of tetramers of type IV collagen (20).  In 
the  present  study,  we  have  used  a  monoclonal  antibody 
prepared against a  fragment of type IX collagen to identify 
822  THE  JOURNAL OF  CELL BIOLOGY • VOLUME  101,  1985 
the structure of the intact type IX molecule as secreted by 
freshly isolated chondrocytes. In the future, it seems probable 
that monoclonal antibodies prepared against protease-resist- 
ant fragments of other poorly characterized collagens will be 
used  to  analyze the  structure  of the  intact  molecule  from 
which these fragments were derived. 
The intact type IX molecule, as observed by rotary shad- 
owing,  fulfills  all  of the  predictions  of its  structure  from 
nucleotide sequencing of cDNA clones. Thus,  from the se- 
quence of pYN  1738, type IX would be expected to have a 
prominent noncollagenous domain only at the amino-termi- 
nus and not at the carboxy-terminus (11). In addition, kinks 
might be anticipated at specific sites along the molecule and 
at least one of the kinks at the NC3 domain can be observed 
in a high proportion of the molecules. The angle of this kink 
does not appear to be fixed, and it is still  not known if the 
kink arises from cleavage of one of the chains by a specific 
processing  event,  or  is  due  to  a  natural  flexibility  of the 
molecule at this site. For HMW, cleavage of only one of the 
chains is known  to occur at this site (2,  10), but  it is  not 
known if  this occurred during pepsin digestion or by an earlier 
cleavage in vivo. 
Type IX collagen is clearly a unique member of  the collagen 
family with several distinctive characteristics. Within the mol- 
ecule there are three separate collagen triple helices,  one of 
which (COL3 or the short arm of HMW) forms a very stable 
helix with a high content of proline and hydroxyproline (2, 
11), and an elevated melting temperature (5). The functional 
significance, if any, of the  COL3 domain is at present un- 
known.  Another unique  feature of type IX collagen  is  the 
apparent covalent linkage of chondroitin  sulfate to at least 
one  of the  chains  (39),  and  type  IX  collagen  is  probably 
related to proteoglycan light (40, 41). It is tempting to specu- 
late that type IX collagen may interact with type II collagen 
and be involved in the organization of the branching network 
of type II collagen fibrils present in hyaline cartilage. It is easy 
to see how such a molecule with several collagenous domains 
between  which  are  very  flexible  noncollagenous  domains 
could  easily be involved in  organizing such  a  network.  In 
addition,  the chondroitin  sulfate chains  present in  type IX 
collagen  may  be  able  to  interact  with  the  large  cartilage 
proteoglycans present between the collagen fibrils.  With the 
preparation of a monoclonal antibody against type IX colla- 
gen for which the location of the epitope is precisely known, 
it may be possible to localize type IX collagen in cartilage 
matrix at high  resolution,  and to  obtain  some evidence in 
support of the above speculations. 
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